PCI Versus CABG: Comparative Effectiveness Study Funded By ARRA Grant
This article was originally published in The Gray Sheet
The American College of Cardiology and Society of Thoracic Surgeons will study the comparative effectiveness of percutaneous coronary intervention and coronary artery bypass graft surgery with a $4 million NIH research grant, announced Oct. 2
You may also be interested in...
Two Health and Human Services agencies will allocate about $250 million this year in comparative effectiveness research funds from the federal stimulus package; the remainder of the $1.1 billion comparative effectiveness money will be put to use in 2010
Analysts and physicians predict one-year results from the SYNTAX trial will have little short-term impact on demand for drug-eluting stents, even though the devices performed worse than coronary artery bypass graft (CABG) surgery in this seminal randomized trial
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.